SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
4.880
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.885
+0.005 (0.10%)
After-hours: Apr 28, 2026, 7:54 PM EDT
SLS Market Cap
SLS has a market cap or net worth of $876.36 million as of April 28, 2026. Its market cap has increased by 769.41% in one year.
Market Cap
876.36M
Enterprise Value
805.57M
1-Year Change
769.41%
Ranking
Category
Stock Price
$4.88
Market Cap Chart
Since March 12, 2008, SLS's market cap has increased from $133.40M to $876.36M, an increase of 556.94%. That is a compound annual growth rate of 10.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 876.40M | 63.20% |
| Dec 31, 2025 | 537.00M | 633.61% |
| Dec 31, 2024 | 73.20M | 115.29% |
| Dec 29, 2023 | 34.00M | -30.04% |
| Dec 30, 2022 | 48.60M | -44.65% |
| Dec 31, 2021 | 87.80M | 59.64% |
| Dec 31, 2020 | 55.00M | 163.16% |
| Dec 31, 2019 | 20.90M | -22.88% |
| Dec 31, 2018 | 27.10M | 125.83% |
| Dec 29, 2017 | 12.00M | -43.13% |
| Dec 30, 2016 | 21.10M | -91.13% |
| Dec 31, 2015 | 238.00M | 29.77% |
| Dec 31, 2014 | 183.40M | -64.87% |
| Dec 31, 2013 | 522.00M | 404.35% |
| Dec 31, 2012 | 103.50M | 412.38% |
| Dec 30, 2011 | 20.20M | -57.38% |
| Dec 31, 2010 | 47.40M | -36.12% |
| Dec 31, 2009 | 74.20M | -6.31% |
| Dec 31, 2008 | 79.20M | -40.63% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 847.57M |
| MannKind | 833.75M |
| Arbutus Biopharma | 827.15M |
| Crescent Biopharma | 823.70M |
| ARS Pharmaceuticals | 823.17M |
| Kura Oncology | 821.94M |
| Cullinan Therapeutics | 800.16M |
| Allogene Therapeutics | 794.59M |